NEW YORK CITY, NY / ACCESS Newswire / February 7, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
Bristol Myers Squibb's FDA nod for Breyanzi (liso-cel) in relapsed/refractory CLL/SLL boosts its CAR T-cell portfolio, ...
Cell Therapy Market Technological breakthroughs, increased funding, and personalized medicine fuel the exponential growth of the global cel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback